Contributions of nitrosoureas to cancer treatment
Mitchell, E.P.; Schein, P.S.
Cancer Treatment Reports 70(1): 31-41
1986
ISSN/ISBN: 0361-5960 PMID: 3002621 Document Number: 271726
Document emailed within 1 workday
Related Documents
Salmon, S.E. 1976: Nitrosoureas: important new drugs for the treatment of cancer Arizona Medicine 33(2): 102-104Wolf, J. 1976: Nitrosoureas as single agents in the treatment of pulmonary cancer Cancer Treatment Reports 60(6): 753-756
Omura, G.A.; Shingleton, H.M.; Creasman, W.T.; Blessing, J.A.; Boronow, R.C. 1978: Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva Cancer Treatment Reports 62(5): 833-835
Calvo, F. 1990: New contributions of biology in breast cancer Pathologie-Biologie 38(8): 769-770
Boyle, J.; Cooney, K.A. 2019: DNA repair genes: contributions to prostate cancer predisposition and aggressiveness Canadian Journal of Urology 26(5 Suppl 2: 10-11
Lee, Y.J.; Wesley, R.A. 1981: Statistical contributions to phase Ii trials in cancer: interpretation, analysis and design Seminars in Oncology 8(4): 403-416
Alavanja, M.; Aron, J.; Brown, C.; Chandler, J. 1987: Cancer risk-assessment models: anticipated contributions from biochemical epidemiology Journal of the National Cancer Institute 78(4): 633-643
Wile, A.G.; Hourani, L.; Schell, M.J. 1993: The contributions of patient factors, physician delay, and tumor biology to the outcome of gastric cancer American Surgeon 59(12): 850-854
Puech, A. 1993: Contributions of pharmacology in the treatment of resistance to antidepressive agents L'Encephale 19(Special Issue 2): 407-412
Hill, D.L.; Kirk, M.C.; Struck, R.F. 1975: Microsomal metabolism of nitrosoureas Cancer Research 35(2): 296-301
Eisenbrand, G.; Müller, N.; Schreiber, J.; Stahl, W.; Sterzel, W.; Berger, M.R.; Zeller, W.J.; Fiebig, H. 1986: Drug design: nitrosoureas Iarc Scientific Publications 78: 281-294
Salmon, S.E. 1976: Nitrosoureas in multiple myeloma Cancer Treatment Reports 60(6): 789-794
Decazes, J.M. 1994: Contributions of experimental models to the physiopathology and treatment of bacterial meningitis La Revue du Praticien 44(16): 2152-2155
Müller, H. 1987: Is Chestnut Lodge salt in the wound of psychoanalytic contributions to the treatment of schizophrenia? Psychiatrische Praxis 14(1): 22-26
Mende, P.; Spiegelhalder, B.; Preussmann, R. 1991: Trace analysis of N-nitrosoureas by their alkylating activity Iarc Scientific Publications 105: 223-225
Schabel, F.M. 1976: Nitrosoureas: a review of experimental antitumor activity Cancer Treatment Reports 60(6): 665-698
Begleiter, A.; Lam, H.P.; Goldenberg, G.J. 1977: Mechanism of uptake of nitrosoureas by L5178Y lymphoblasts in vitro Cancer Research 37(4): 1022-1027
Stahl, W.; Krauth-Siegel, R.L.; Schirmer, R.H.; Eisenbrand, G. 1987: A method to determine the carbamoylating potential of 1-(2-chloroethyl)-1-nitrosoureas Iarc Scientific Publications 84: 191-193
Kohn, K.W. 1977: Interstrand cross-linking of DNA by 1,3-bis(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitrosoureas Cancer Research 37(5): 1450-1454
Ruland, C.M.; Slaughter, L.; Starren, J.; Vatne, T.M.; Moe, E.Y. 2007: Children's contributions to designing a communication tool for children with cancer Studies in Health Technology and Informatics 129(Pt 2): 977-982